Optibrium expands 3D drugs offering with BioPharmics acquisition 04-Sep-2023 By Isabel Cameron Optibrium, a developer of software and AI solutions for drug discovery, has acquired BioPharmics in a view to expand its 3D drug design and modelling offering.